Publication | Open Access

Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials

OncologyIpilimumab TreatmentClinical TrialsMetastatic SarcomaAlliance A091401Immune Checkpoint InhibitorPharmacotherapyCancer TreatmentMedicineRadiation OncologyHealth Sciences